Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohortTenna Vesterman Henriksen, Claus L. Andersen, Nis H. Schlesinger et al.|Annals of Oncology|2023Cited by 71
Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal CancerJonas Kabel, Claus L. Andersen, Tenna Vesterman Henriksen et al.|Cancers|2023Cited by 12
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancerNadia Øgaard, Claus L. Andersen, Sarah Østrup Jensen et al.|British Journal of Cancer|2024Cited by 10
Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal CancerTenna Vesterman Henriksen, Claus L. Andersen, Christina Demuth et al.|Clinical Cancer Research|2025Cited by 7
The role of renal and liver function in clinical ctDNA testingJohn A. Conrad, Claus L. Andersen, Tenna Vesterman Henriksen et al.|PLoS ONE|2025Cited by 4